US-Listed Pharmaceutical Preparations — Net Income Percentiles
Population: 490 US-listed companies (SIC 2834), most recent complete fiscal year per filer; fiscal year ends 2025-03-31 to 2026-06-30.
| 10th percentile | $-209.5M |
|---|
| 25th percentile | $-83.7M |
|---|
| Median | $-24.1M |
|---|
| 75th percentile | $-4.7M |
|---|
| 90th percentile | $42.2M |
|---|
| Mean | $-16.1B |
|---|
| Minimum | $-8.0T |
|---|
| Maximum | $26.8B |
|---|
Methodology & sources
Net Income as filed in the most recent complete fiscal year per company (period > 300 days, fiscal year end within the last 18 months); percentiles computed in the database via percentile_cont, never by a model.
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, as of 2026-06-30.
Scope: {"source": "SEC EDGAR: api.mv_sic x api.v_company_financials (as-filed)", "selection": "je Firma das jüngste volle Geschäftsjahr (>300 Tage, Ende in den letzten 18 Monaten); Umsatzband filtert über de
Evidence samples
Query this live via API/MCP (template peer_percentiles); terms: /nutzung. Cite as: FACTANKER, https://factanker.com/industries/sic-2834/net-income